By Dr Ashraf Zaman

Conference Abstracts

Yuile A; Satgunaseelan L; Alexander KL; Thavaneswaran S; Sim H-W; Zaman A; Powell J; Meng A; Escher C; Wei JQ; Wei G; Lee M; Buckland ME; Kong BY; Kastelan M; Wong M; Wilson I; Bayly A; Varikatt W; Lwin Z; Rodriguez M; Soh HC; Gill A; Zakarya R; Back MF; Pavlakis N; Chan DL; Lee A; Wheeler HR; Hudson AL, 2025, 'PATH-18. Investigating the role of CDKN2A loss in IDH-mutant gliomas: biological insights beyond tumour grading', in Neuro-Oncology, Oxford University Press (OUP), Vol. 27, pp. v243 - v244, http://dx.doi.org/10.1093/neuonc/noaf201.0970

Southi N; Sim H-W; Grady J; Satgunaseelan L; Huang M; Kansara M; Yuile A; Zaman A; Lin F; Wheeler H; Hudson A; Ballinger ML; Thomas DM; Thavaneswaran S, 2025, 'PATH-52. Understanding the prevalence ofMTAP andCDKN2A/B deletion in gliomas by next generation sequencing', in Neuro-Oncology, Oxford University Press (OUP), Vol. 27, pp. v252 - v252, http://dx.doi.org/10.1093/neuonc/noaf201.1004

Back to profile page